article thumbnail

Tech Theatre ELRIG 2022: First steps towards liquid handling automation

Drug Discovery World

in Chemical Biology. She completed her academic training with a post-doctoral career development fellowship in Protein Engineering at the MRC Laboratory of Molecular Biology in Cambridge, UK. Hammerstein graduated from the University of Oxford with a M.Chem. in Chemistry and D.Phil.

article thumbnail

Advancements in upstream CLD for enhanced biotherapeutics production

Drug Discovery World

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School and a PhD in Virology/Molecular Biology. The post Advancements in upstream CLD for enhanced biotherapeutics production appeared first on Drug Discovery World (DDW).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The inner workings of environmental bacterium

Drug Target Review

A team led by Professor Dr Ralf Rabus, a microbiologist at the University of Oldenburg, in collaboration with his doctoral student Patrick Becker, has achieved profound insights into the inner workings of a prevalent environmental bacterium.

article thumbnail

My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference

Alta Sciences

Our experts have over five years of experience with CRISPR gene-editing therapeutics in nonhuman primates (NHPs) and extensive expertise in bioanalysis for biodistribution studies, in addition to many molecular biology platforms , such as ligand binding assays (LBA), NAbs, TAbs, flow cytometry , and ELISpot.

article thumbnail

Meet the researcher: Dr Stephen Jones

Drug Discovery World

Biography: Credit: Jurgita Satkūnaitė Originally from the US, Stephen Jones earned his doctorate in Molecular Biology, Cellular Biology and Biochemistry at Brown University. It improved my written communication so much, and it’s a resource I continually find myself referring back to.

Research 147
article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School, and a PhD in virology/molecular biology. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.

article thumbnail

Turning science into business: An optimised alternative to antibodies

Drug Discovery World

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD.

Science 130